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Voltage-gated sodium channela b s t r a c t
Chronic visceral pain affects millions of individuals worldwide and remains poorly understood, with
current therapeutic options constrained by gastrointestinal adverse effects. Visceral pain is strongly
associated with inflammation and distension of the gut. Here we report that the voltage-gated sodium
channel subtype NaV1.9 is expressed in half of gut-projecting rodent dorsal root ganglia sensory neurons.
We show that NaV1.9 is required for normal mechanosensation, for direct excitation and for sensitization
of mouse colonic afferents by mediators from inflammatory bowel disease tissues, and by noxious
inflammatory mediators individually. Excitatory responses to ATP or PGE2 were substantially reduced
in NaV1.9/ mice. Deletion of NaV1.9 substantially attenuates excitation and subsequent mechanical
hypersensitivity after application of inflammatory soup (IS) (bradykinin, ATP, histamine, PGE2, and
5HT) to visceral nociceptors located in the serosa and mesentery. Responses to mechanical stimulation
of mesenteric afferents were also reduced by loss of NaV1.9, and there was a rightward shift in stimu-
lus–response function to ramp colonic distension. By contrast, responses to rapid, high-intensity phasic
distension of the colon are initially unaffected; however, run-down of responses to repeat phasic disten-
sion were exacerbated in NaV1.9/ afferents. Finally colonic afferent activation by supernatants derived
from inflamed human tissue was greatly reduced in NaV1.9/ mice. These results demonstrate that
NaV1.9 is required for persistence of responses to intense mechanical stimulation, contributes to inflam-
matory mechanical hypersensitivity, and is essential for activation by noxious inflammatory mediators,
including those from diseased human bowel. These observations indicate that NaV1.9 represents a
high-value target for development of visceral analgesics.
Crown Copyright  2014 Published by Elsevier B.V. on behalf of International Association for the Study of
Pain. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).1. Introduction
Chronic dysregulation of visceral sensation can lead to abdom-
inal pain, which is clinically challenging to treat. A hallmark of
chronic visceral pain is heightened sensitivity to gut motility anddistension of visceral organs, typically in response to past or ongo-
ing inflammation [26]. In some patient groups, therapeutic inhibi-
tion of mechanosensitivity in visceral afferents has proven
effective in treating pain [51,52]. However, opportunities for
improved intervention will likely come from targeting mecha-
nisms of activation common to both inflammatory and mechanical
stimulation of the viscera.
The activity of voltage gated sodium channels (NaV) underpins
electrogenesis in excitable cells. The 9 genes (SCN1A–SCN5A and
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tissue specific expression and describe proteins with varying
biophysical characteristics. Of those expressed in peripheral
neurons, 3 channels (NaV1.7, NaV1.8, and NaV1.9) are strongly
associated with pain behaviours in both rodents and humans.
Specifically, NaV1.9 mediates a slowly inactivating persistent
sodium current that is activated at voltages close to the resting
membrane potential of sensory neurones. As a consequence of
these biophysical properties, NaV1.9 is proposed to contribute to
the resting membrane potential and regulate nerve terminal
excitability [3]. More recently, we, as well as others, have shown
that the NaV1.9 sodium current may be enhanced by the algogenic
mediator, ATP, and the inflammatory mediator PGE2, acting
through G protein–coupled pathways, suggesting that NaV1.9
may also play an important role in the activation of sensory nerves
by inflammatory mediators [2,30,44]. This hypothesis is supported
for somatic pain by behavioural studies demonstrating reduced
hypersensitivity to inflammatory stimuli in rodents where NaV1.9
has been deleted or knocked down [1,28,39]. However, evidence
for a role of NaV1.9 in visceral pain processing is controversial, with
behavioural studies in NaV1.9 knockout mice reporting either
reduced or enhanced pain behaviours to noxious stimuli
[27,31,41]. Similarly the extent to which NaV1.9 is expressed
within visceral afferents is far from clear [4,24]. As a consequence,
the contribution of NaV1.9 to visceral afferent sensitivity remains
to be defined.
We hypothesized that the persistent sodium current mediated
by NaV1.9 plays a significant role in the polymodal sensitivity of
visceral afferents to inflammatory mediators and the subsequent
development of hypersensitivity to mechanical stimuli. We
therefore investigated effects of NaV1.9 gene deletion on the
response of visceral afferents to inflammatory and mechanical
stimuli, and NaV1.9 expression in colon-projecting sensory
neurons.2. Materials and methods
All experimental studies were performed in accordance
with the UK Animal (Scientific Procedures) Act of 1986. Human
tissue was collected and used with approval of the East London
and the City HA Local Research Ethics Committee (NREC 10/
H0703/71).2.1. In vitro mouse colonic splanchnic afferent preparations
NaV1.9/ mice were rederived from NaV1.9+/ breeding pairs
and originally generated by homologous recombination on a C57/
BL6 background, as described previously [36]. Adult NaV1.9+/+ or
NaV1.9/ mice of either sex were euthanized by rising concentra-
tion of CO2, and the distal colon with associated lumbar splanchnic
nerves removed. For whole-nerve experiments, tissues were cann-
ulated, luminally perfused (100 lL/min), and serosally superfused
(7 mL/min; 32–34C) with carbogenated Krebs buffer (in mM:
124 NaCl, 4.8 KCl, 1.3 NaH2PO4, 2.5 CaCl2, 1.2 MgSO47H2O, 11.1
glucose, and 25 NaHCO3) supplemented with nifedipine (10 lM)
to block smooth muscle contraction, and indomethacin (3 lM) to
block endogenous prostanoid production. Atropine (10 lM), the
muscarinic acetylcholine receptor antagonist, was also added to
the Krebs buffer to further prevent smooth muscle contractions.
For single-fibre recordings, tissues were perfused with supple-
mented Krebs as described above; however, the colon was opened
along the antimesenteric border and pinned with the flat mucosal
side up. This preparation has been described in detail previously
[6,8,19].2.2. Electrophysiological recordings and characterization of colonic
splanchnic afferent properties
Borosilicate glass suction electrodes were used to record multi-
unit activity from whole lumbar splanchnic nerves (rostral to the
inferior mesenteric ganglia) or single-unit activity from fibres
teased from lumbar splanchnic nerves. Signals were amplified,
band pass filtered (gain 5 K; 100–1300 Hz; Neurolog, Digitimer
Ltd, UK), and digitally filtered for 50 Hz noise (Humbug, Quest Sci-
entific, Canada). Raw traces were digitized at 20 kHz (micro1401;
Cambridge Electronic Design, UK), and action potential firing
counts were determined using a threshold of twice the background
noise (typically 100 lV). All signals were displayed on a PC using
Spike 2 software. In flat sheet preparations, distinct receptive fields
were identified and characterized according to previously pub-
lished classifications by graded stimulus–response to punctate
von Frey hair (vFh) probing (0.07 g, 0.16 g, 0.4 g, 1 g, and 2 g; each
applied 3 times for a period of 3 s), circumferential stretch (0 g, 5 g,
and 10 g; each weight applied for 1 min, with an interval of 1 min
between applications), and mucosal stroking with light vFh
(0.16 g; applied 10 times) [6,19,21]. A cantilever system was used
to apply stretch via a thread attached with a purpose-made claw to
the tissue adjacent to the receptive field. Addition of weights to the
end of the cantilever system initiated colonic stretch. Four distinct
classes of afferent fibre were identified on the basis of these
responses: muscular (those responding to low-intensity circumfer-
ential stretch [65 g], but not fine mucosal stroking); mucosal
(those responding to light vFh stroking), mesenteric (those
responding to focal compression of the mesentery), and serosal
(those responding to focal compression of the colon wall, but not
low-intensity stroke or low-intensity circular stretch). In addition,
conduction velocity was calculated for serosal and mesenteric
units by dividing evoked action potentials latency elicited after
electrical stimulation (0.5 Hz, 15 V, 1 ms) of the receptive field
with concentric stimulating electrodes by the distance from the
recording electrode to receptive field.2.3. Retrograde labelling of colonic sensory neurones
Fast Blue (FB; 2% in saline, Polysciences Gmbh, Germany) was
injected into the wall of the distal colon of NaV1.9+/+ and
NaV1.9/ mice and male Sprague Dawley rats (150–250 g).
Briefly, animals were anaesthetized with isoflurane then an
approximate 1.5 cm laparotomy performed. Five injections of
0.2 lL FB per site, at a rate of 0.4 lL/min via a microinfusion
pump, were made into the wall of the distal colon using a fine-
pulled glass needle. The muscle layer was sutured and the skin
secured with Michel clips. Postoperative analgesia (buprenor-
phine 0.05–0.1 mg/kg daily) and care (monitoring body weight
and soft diet) was provided.
After 3 days for mice and 7 days for rats, animals were eutha-
nized with sodium pentobarbital (200 mg/kg i.p.) and transcar-
dially perfused with saline (0.9%) followed by paraformaldehyde
(4% in 0.1 M phosphate buffer; pH 7.4). Dorsal root ganglia
(DRG; NaV1.9+/+ and NaV1.9/ mice, T13–L1; rats, L2) were
removed and postfixed in 4% paraformaldehyde for 2 h and
cryoprotected in 30% sucrose (w/v phosphate-buffered saline).
Cryostat sections (10 lm) were collected sequentially across 10
slides per DRG.2.4. Immunohistochemistry
Sections were blocked in antibody diluent (10% horse serum
and 0.2% (v/v) Triton X-100 in 0.1 M phosphate-buffered saline)
for 1 h, followed by overnight incubation with primary antibodies
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anti-CGRP antibody [1:2000; Abcam, UK]) and a 4 h incubation
with fluorophore conjugated secondary antibodies (donkey anti-
rabbit IgG-Alexafluor-488 and donkey anti-goat IgG-Alexafluor-
568 [1:1000; Invitrogen, UK]) and/or isolectin B4 [IB4] from
Griffonia simplicifolia–Alexafluor-647 (2.5 lg/mL; Invitrogen, UK).
No labelling was observed in control experiments where the
primary antibody was excluded or in the presence of a competing
blocking peptide.
2.5. In situ hybridization
Oligonucleotide probes complementary to bases 968 to 1001
(probe 1) and 2641 to 2674 (probe 2) of the mouse SCN11A
sequence, accession number NM 011887.3, were synthesized
(Sigma, UK), end labelled with 35S, and hybridized to DRG sections
using previously described protocols and visualized by silver grain
development in radiographic emulsion [32]. No specific labelling
was observed in DRG sections of NaV1.9/ mice hybridized with
SCN11A probes; reactions where an excess of unlabelled probe
was used resulted in only background signal.
2.6. Imaging and quantitation
Sections were imaged and the relative intensities of reaction
products after immunostaining for NaV1.9 and other markers and
SCN11A mRNA in situ hybridization were determined for all DRG
cells with visible nuclei (ImageJ 1.45S analysis software, NIH,
USA). The mean background absorbance was subtracted to control
for variability in illumination. Percentage relative intensities of
background-subtracted cell absorbance were determined by com-
parison with least intensely (0%) and most intensely (100%)
labelled profiles. For in situ hybridization, relative intensity of
DRG cells was measured in NaV1.9/ sections to set the threshold
for positive labelling in wild-type mice. Cells with intensity values
greater than the mean intensity of the 10 cells with highest back-
ground intensity values in NaV1.9/ sections plus 2 times its SD
were considered positively labelled. For NaV1.9, CGRP and IB4-like
immunostaining, intensity of staining was scored on a scale of 0 to
5 by 2 independent observers, with 0 representing negative and 5
strongly positive. The mean absorbance of these cells taken from
ImageJ analysis correlated with staining scores (eg, Pearson
r = 0.87; P < .0001; n = 149) and a threshold for positive staining
was determined as performed by Fang et al. [13] (eg, mean absor-
bance for NaV1.9P 32%).2.7. Generation of human tissue supernatants
Resected human colon was obtained after full written consent
was obtained from patients undergoing elective surgery at Barts
Health NHS Trust, London, after approval by the local research eth-
ics committee (NREC 10/H0703/71). Patient details are outlined in
Table 1. Control supernatants were generated using macroscopi-
cally normal colon (>10 cm from tumour margin) obtained from
patients (male/female ratio, 2/1; mean age, 61 years) undergoing
colectomy as part of their normal surgical treatment for bowel can-
cer. Disease tissue supernatants were derived from chronically
inflamed colon or intestine obtained from patients undergoing
operations as part of their standard surgical treatment for Crohn
disease (CD) (male/female ratio, 7/3; mean age, 30 years) or ulcer-
ative colitis (UC) (male, 4; mean age, 22 years). All patients had
active disease which was unresponsive to medical treatment. Tis-
sue samples were incubated in fresh carbogenated Krebs buffer
at 37C for 25 min at a fixed volume of 2.5 mL/g of tissue. After
incubation, the tissue was removed and the buffer centrifuged at2000  g for 10 min. The remaining supernatant was formed into
aliquots and stored at 80C until use.
2.8. Inflammatory cytokine quantification
Quantitative analysis of protein cytokine levels was performed
on supernatant samples using established capture sandwich
immunoassay and magnetic microsphere methodology [34].
Samples were prepared as per manufacturer’s instructions
(Invitrogen, UK) and analysed with the Luminex MAGPIX detec-
tion system (Luminex, TX, USA) for IL-1b, IL-6, GM-CSF, TNF-a,
and IL-8.
2.9. Electrophysiology protocols
In multiunit experiments, drugs were applied after a stabiliz-
ing period of 30 min by bath superfusion of a 20 mL volume.
Where repeat concentrations of drugs were given, a minimum
60 min interval was maintained. Increasing concentrations of
ATP (0.1, 1.0, and 3.0 mM) or PGE2 (3 lM) were applied in sepa-
rate colonic preparations. Supernatants derived from CD, UC, and
control tissues were applied by 20 mL bath superfusion in sepa-
rate colonic preparations. Ramp distensions were performed by
blocking luminal perfusion out-flow of the cannulated colon pro-
ducing noxious pressures known to both evoke pain behaviours
in vivo in mice and robustly activate all known afferent mechano-
receptors (0–80 mmHg; [21,35]). In later studies, ramp disten-
sions from 0 to 145 mm Hg (4–5 min) were conducted to
provide a supraphysiological pressure. Response to 0 to 80 mm
Hg ramp distension was also investigated after pretreatment
(20 min) with and in the presence of intraluminally perfused IS.
In some studies, ramp distensions were performed once firing
rates had returned to baseline activity after drug application. Sets
of 6 rapid phasic ramp distensions (0–80 mm Hg, 60 s at 9 min
intervals) were implemented in separate experiments. Single-
fibre studies were only performed on muscular, mesenteric, or
serosal units as a result of the sparse nature of mucosal splanch-
nic afferents. In all 3 types of units, mechanosensitivity was
examined in response to graded vFh probing (0.07 g, 0.16 g,
0.4 g, 1 g, and 2 g) and circumferential stretch (0 g, 5 g, and
10 g). In mesenteric and serosal units, the effect of applying either
an IS (consisting of 1 lM bradykinin, 1 mM ATP, 10 lM hista-
mine, 10 lM PGE2, and 10 lM 5HT; 2 min) or CD inflammatory
supernatant (5 min) to receptive fields isolated by a metal ring
was also examined on ongoing nerve discharge. Additionally,
changes in the response to vFh probing with a 2 g hair were
examined before and after application of IS or supernatant.
2.10. Data analysis
In multiunit experiments, peak changes and time profiles of
electrophysiological nerve activity were determined by subtracting
baseline firing (5 min before drug application) from increases in
nerve activity after drug/supernatant superfusion or ramp disten-
sion. Changes in nerve activity were compared between NaV1.9+/+
and NaV1.9/ animals by Student’s t test or 2-way ANOVA with
Bonferroni post hoc test, as appropriate. In teased single-fibre flat
sheet experiments, average spikes/s per stimulus were compared
between genotype or before and after ring application of drugs/
supernatants. All cytokine quantification data were analysed non-
parametrically. If detectable levels of cytokines were present in
control supernatants, Mann-Whitney U tests were performed, or
else Wilcoxon signed rank tests comparing to a theoretical median
of 0.0 were performed. Statistical significance was set at P < .05.
Data are presented as mean ± SEM, N = number of animals, and
n = number of observations.
Table 1
Patient details of human tissue used in the present studies.a
Patient no. Disease Operation Age Sex Cytokine analysis Whole nerve Single fibre
1 Cancer Laparoscopic anterior resection 50 F Y Y
2 Cancer Right hemicolectomy 76 M Y Y
3 Cancer Subtotal colectomy 57 M Y Y
Mean age/M:F ratio 61 2:1
5 CD Laparotomy and proceed 21 F Y Y Y
6 CD Redo right hemicolectomy 30 F Y Y Y
7 CD Right hemicolectomy 21 M Y Y
8 CD Completion colectomy 25 M Y
9 CD Subtotal colectomy 30 M Y
10 CD Small bowel resection 24 F Y
11 CD Small bowel resection 42 M Y
12 CD Colectomy and end ileostomy 28 M Y
13 CD Extended right hemicolectomy 16 M Y
14 CD Subtotal colectomy 64 M Y
Mean age/M:F ratio 30 2.3:1
15 UC Subtotal colectomy 21 M Y Y
16 UC Restorative proctocolectomy 20 M Y Y
17 UC Subtotal colectomy 30 M Y Y
18 UC Restorative proctocolectomy 18 M Y Y
Mean age/M:F ratio 22 4:0
CD, Crohn disease; UC, ulcerative colitis.
a Supernatants generated from these tissues have been used for inflammatory cytokine quantification (cytokine analysis), 20 mL bath superfusion of whole-nerve
recordings from the lumbar splanchnic nerve (whole nerve), or discrete ring application to characterized receptive fields in a flat sheet preparation and single-fibre recording
from the lumbar splanchnic nerve (single fibre).
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Stock concentrations of ATP (300 mM; water), PGE2 (1 mM; eth-
anol), bradykinin (10 mM; water), histamine (100 mM; water),
5HT (10 mM; water), atropine (10 mM; ethanol), indomethacin
(3 mM; DMSO) and nifedipine (10 mM; DMSO) were all purchased
from Sigma Aldrich (UK) and prepared as described. IS was pre-
pared in advance and aliquots frozen until use. All compounds
were diluted to working concentrations in buffer on the day of
experimentation.
3. Results
3.1. Localization of NaV1.9 in visceral afferent neurons
We first examined the expression of NaV1.9 transcripts in
colon-projecting thoracolumbar DRG sections of mouse via
in situ hybridization (ISH). Under polarized light, NaV1.9-positive
labelling was observed as clusters of silver grains visible over cells
and was present in 69.0 ± 3.0% of all neurons comparable with pre-
vious studies in rat (Fig. 1) [11,18]. Injections of FB retrograde tra-
cer into the colon wall labelled 6.7 ± 1.8% of thoracolumbar DRG
neurons in NaV1.9+/+ mice (Fig. 1Aii), and of these, 50.5 ± 3.3%
expressed NaV1.9 transcripts. A similar proportion of FB-positive
colonic neurons were found in NaV1.9/ mice (8.3 ± 0.9% vs
NaV1.9+/+ FB positive, P = .46), indicating no loss or lesion of these
cells. Importantly, no specific NaV1.9 expression was observed in
sections from NaV1.9/ mice (Fig. 1B) and those incubated with
excess unlabelled probe (data not shown). Size–frequency analysis
of all neurons revealed that NaV1.9 mRNA was expressed to a
higher extent in small (<20 lm diameter, 83.4 ± 2.9%) compared
to medium to large (>20 lm diameter, 50.2 ± 2.9%) neurons. In
the FB-positive population, a similar distribution was seen with
71.1 ± 10.9% small-diameter and 44.5 ± 3.6% medium-large diame-
ter cells expressing NaV1.9 transcripts (Fig. 1D).
To further characterize NaV1.9 protein expression and confirm
our mRNA distribution data, we used a commercially available
NaV1.9 antibody in rat DRG sections. Additionally, this was
performed in conjunction with CGRP and IB4 labelling, on the basis
of the strong correlation between IB4 binding and NaV1.9expression reported previously (Fang 2006). The NaV1.9 antibody
produced nonspecific labelling in mouse DRG but proved highly
specific in rat tissues [53]. No specific staining was seen in control
experiments after omission of the NaV1.9 antibody or preincuba-
tion with blocking peptide (data not shown). Rat NaV1.9 immuno-
reactivity was observed in a similar proportion of total neurons
(64.5 ± 2.4%, Fig. 2A) to mouse ISH, and colonic injection of FB
labelled a similar proportion of neurones in rat DRGs (9.2 ± 1.6%).
In agreement with the mouse ISH data in FB-positive neurones,
51.9 ± 5.8% of rat FB-positive cells stained positive for NaV1.9 pro-
tein. As expected, a greater proportion of CGRP-expressing cells
(80.6 ± 8.3%) was observed in the colon-projecting population
compared to all neurons (34.8 ± 1.1%, Fig. 2B, C), indicative of an
enriched peptidergic population [42]. The extensive colocalization
of NaV1.9 with IB4 staining predicted by previous studies was also
observed in FB-negative neurons (73.4 ± 3.5% of NaV1.9; Table 2)
[14]. By contrast, NaV1.9/IB4 colocalization was less extensive
(34.7 ± 7.3% of NaV1.9) in FB-positive colonic populations, with
an enrichment of colocalization with CGRP (from FB negative:
32.7 ± 1.1% to FB positive: 89.6 ± 7.8% of NaV1.9, Fig. 2B, C). As such,
within the colon-projecting population, NaV1.9 appears to be
almost exclusively expressed in CGRP-positive neurons.
3.2. Deletion of NaV1.9 inhibits colonic afferent responses to ATP and
PGE2
To investigate the role of persistent tetrodotoxin-resistant
sodium current activation in responses of visceral afferents to
ATP and PGE2, we made extracellular recordings of the lumbar
splanchnic nerve in NaV1.9+/+ and NaV1.9/ mice. Multiunit
recordings provided an unbiased observation of the involvement
of NaV1.9 in lumbar splanchnic nerve responses to superfused
application of ATP and PGE2. Baseline firing was reduced in
NaV1.9/ mice compared to control animals (0.7 ± 0.1 spikes/s,
N = 41 vs 1.4 ± 0.3 spikes/s, N = 49; P < .05). The sequential applica-
tion of increasing ATP concentrations led to robust and concentra-
tion-dependent increases in afferent firing (Fig. 3) in control mice.
PGE2 (3 lm) also evoked comparable afferent excitation (Fig. 4).
However, in NaV1.9/ mice, responses to ATP and to PGE2 were
significantly diminished for the duration of the response. Even at
Fig. 1. Expression of NaV1.9 mRNA in visceral colonic sensory neurons in mouse. Radiographic in situ hybridization of NaV1.9 mRNA transcript expression (bright field with
Giemsa counterstain, i; polarized light, iii) in thoracolumbar dorsal root ganglia (DRG) section from NaV1.9+/+ (A) and NaV1.9/ (B) mice combined with retrograde labelling
of sensory neurons from the colon with Fast Blue (FB) (FB only, ii; merge, iv; scale bar = 50 lm). (C) Expanded top-right region of NaV1.9+/+ ganglia section (A) showing 4
retrogradely labelled sensory neurons (scale bar = 30 lm). Yellow arrows indicate colon projecting neurons positive for NaV1.9 expression. Yellow arrowheads indicate colon
projecting neurons negative for NaV1.9 expression. (D) Cross-sectional area histogram of Fast Blue–positive neurons from NaV1.9+/+ mice superimposed with those which also
exhibit NaV1.9 mRNA transcript expression (N = 4).
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nerve terminal sensitivity were reduced by 73% in NaV1.9/
afferents.
3.3. Effects of NaV1.9 deletion on responses of colonic afferents to IS
and subsequent mechanical hypersensitivity
We next investigated a more generic role for NaV1.9 in afferent
responses to multiple inflammatory mediators. To achieve this,
single-fibre recordings were made in colonic flat sheet prepara-
tions, and receptive fields in the mesentery and serosa were iden-
tified. A mixture of multiple inflammatory mediators commonly
used in pain studies was applied [15,23,49]. Discrete application
of IS (bradykinin, ATP, histamine, serotonin, and PGE2) for 2 min
in a small chamber surrounding the receptive field led to robust
activation in 100% of serosal and 80% of mesenteric units in
NaV1.9+/+ mice (Fig. 5). In line with our previous whole-nerve
recordings of responses to ATP and PGE2, the increase in firing of
single afferent fibres after IS was statistically reduced in
NaV1.9/ mice, and only 43% of serosal (P < .05) and 56% of
mesenteric (P < .05) units responded (Fig. 5C).
After responses to IS, mechanical hypersensitivity of colonic
afferents was seen. We compared responses to 2 g vFh probingbefore and after IS application in control animals and observed a
significant increase in responses after IS (P < .05, Fig. 5D). This is
consistent with previous studies using the application of bradyki-
nin [7]. IS-induced mechanical hypersensitivity to a 2 g probe
was completely lost in NaV1.9/mice (serosal, P = .76; mesenteric,
P = .63), indicating that NaV1.9 may directly influence mechanical
hypersensitivity of visceral afferents induced by IS.
3.4. NaV1.9 deletion reduces colonic afferent responses to human
tissue–derived inflammatory supernatants
We investigated whether ablation of NaV1.9 would also alter
responses to supernatants derived from inflamed human tissue.
To do this, resected bowel tissue from patients undergoing surgery
for inflammatory bowel disease (IBD; CD and UC) was incubated in
Krebs solution to generate individual IBD supernatants. Separately,
macroscopically normal tissue taken from bowel cancer resections
(>10 cm away from the cancer itself, cancer margins, and lymph
nodes) was used to generate control supernatants. These control
supernatants enabled possible excitatory effects caused by surgical
manipulation, removal of tissue, and temporal ischaemia to be
discounted from afferent activation driven by inflammatory
mediators released from native tissue. Importantly, no further
Fig. 2. Expression of NaV1.9 in visceral colonic sensory neurons in rat. (A) Multiple fluorescent immunohistochemistry of NaV1.9 (i) and CGRP (iii) immunoreactivity and IB4
binding (iv; scale bar = 50 lm) in dorsal root ganglia from rat combined with retrograde labelling of sensory neurons from the colon (ii, merge of NaV1.9-IR and FB). Solid
arrows indicate Fast Blue (FB)-positive neurons with NaV1.9, CGRP, and IB4 (white) or NaV1.9 and CGRP (orange). Open arrows indicate example FB-negative neurons with
NaV1.9, CGRP, and IB4 (white) or NaV1.9 and IB4 (light blue). (B) Proportional Venn diagram of coimmunoreactivity for NaV1.9 and CGRP and IB4 binding in neuronal
populations retrogradely labelled from the colon in rat. Approximately 13.3% of FB-positive neurons were negative for NaV1.9, CGRP, and IB4 binding (N = 3). (C) Proportional
Venn diagram of coimmunoreactivity for NaV1.9 and CGRP and IB4 binding in noncolonic neuronal populations (FB negative) in rat. Approximately 21.6% of FB-negative
neurons were negative for NaV1.9, CGRP, and IB4 binding (N = 3).
Table 2
Comparison of NaV1.9 and CGRP immunohistochemical expression and IB4 binding in colonic and noncolonic sensory neurons.a
Characteristic Colonic (FB positive; N = 4, n = 247) Noncolonic (FB negative; N = 4, n = 2556)
NaV1.9-IR 51.9 ± 5.8% 65.9 ± 3.0%
CGRP-IR 80.6 ± 8.3% 30.0 ± 0.4%
IB4 binding 26.0 ± 5.3% 54.1 ± 0.9%
% of NaV1.9 % of CGRP % of NaV1.9 % of CGRP
NaV1.9 and CGRP-IR 89.6 ± 7.8% 57.7 ± 5.1% 32.7 ± 1.1% 71.7 ± 3.5%
% of NaV1.9 % of IB4 % of NaV1.9 % of IB4
NaV1.9-IR and IB4 binding 34.7 ± 7.3% 68.5 ± 7.7% 73.4 ± 3.5% 89.2 ± 2.1%
FB, Fast Blue; CGRP, calcitonin gene–regulated peptide; IB4, isolectin-B4; IR, immunoreactivity.
a Percentage coexpression in terms of total stated marker.
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To confirm the inflammatory status of the supernatants, cytokine
quantification for IL-6, IL-8, IL-1b, GM-CSF, and TNF-a was
performed. In control supernatants, there were detectable levels
of IL-6 (7.5 ± 3.3 pg/mL) and IL-8 (43.4 ± 13.8 pg/mL), with levels
of the remaining cytokines below detection limits (Fig. 6D).
Cytokine levels were all significantly elevated in IBD supernatants
(IL-1b: 35.4 ± 22.7; IL-6: 598.6 ± 276.3; GM-CSF: 37.5 ± 14.9;
TNF-a: 31.5 ± 23.6; IL-8: 3419.3 ± 2083.7 pg/mL; each cytokine vs
control, P < .05), with cytokine levels greatest in supernatants
generated from CD tissue compared to those of UC [(IL-1b:
8.8 ± 3.6; IL-6: 186.4 ± 32.5; GM-CSF: 15.7 ± 3.0; TNF-a: 6.2 ± 2.1;IL-8: 1040.0 ± 231.2 pg/mL) CD: (IL-1b: 75.7 ± 46.3; IL-6:
1157.0 ± 507.8; GM-CSF: 66.8 ± 27.9; TNF-a: 64.0 ± 54.4; IL-8:
6446.0 ± 4715.0 pg/mL)]. It should be mentioned that the influence
on cytokine production by immunosuppressant and anti-TNF-a
antibody therapies was not accounted for during patient selection.
Supernatants were applied to mouse whole-nerve lumbar splanch-
nic recordings in a cannulated tubular preparation, similar to that
used for ATP and PGE2 application. IBD supernatants elicited a
robust increase in afferent firing compared to control supernatants
in wild-type animals (3.5 ± 0.5 spikes/s vs control supernatant
0.7 ± 0.1 spikes/s, P < .01, Fig. 6C). In NaV1.9/ mice, the response
to IBD supernatants was greatly attenuated and almost comparable
Fig. 3. Effect of increasing concentrations of ATP on colonic splanchnic nerve activity in NaV1.9+/+ and NaV1.9/ mice. Example rate histogram and neurogram response in
NaV1.9+/+ (A) and NaV1.9/ (B) mice to 0.1 mM, 1 mM, and 3 mM ATP. Below, expanded traces at baseline and after addition of 3 mM ATP and example action potential for
each genotype. (C) Response profiles to addition of 1 mM ATP in NaV1.9+/+ (N = 6) and NaV1.9/ mice (N = 6). (D) Peak increase in nerve activity after addition of 0.1 mM,
1 mM, and 3 mM ATP above baseline activity in NaV1.9+/+ (N = 6) and NaV1.9/ (N = 6) mice. ⁄⁄P < .01, ⁄⁄⁄P < .001.
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(1.2 ± 0.3 spikes/s, vs NaV1.9+/+ mice, P < .01). We then investigated
the effect of application of CD supernatants to individual isolated
receptive fields using single-fibre recordings in flat sheet prepara-
tions. Responses to application of CD supernatant were seen in 64%
of serosal (1.37 ± 0.36 spikes/20 s) and 50% of mesenteric afferents
(1.13 ± 0.22 spikes/20 s) (Fig. 6E). The proportions of units
responding in NaV1.9/ mice were comparable (P = 1.00, Fig. 6F);
however, the degree of afferent activation elicited by application
of CD supernatant to receptive fields was significantly less
(serosal: 0.31 ± 0.11 spikes/20 s, P < .05 vs NaV1.9+/+; mesenteric:
0.42 ± 0.16 spikes/20 s, P < .05 vs NaV1.9+/+). Unlike effects of
experimental IS, no mechanical hypersensitivity was observed
after CD supernatant in either NaV1.9+/+ or NaV1.9/ mice to 2 g
vFh probe (data not shown), regardless of whether afferents
showed direct excitation to supernatant. However, it is clear that
NaV1.9 contributes to direct afferent excitation by both artificial
and natural inflammatory milieu of differing composition.
3.5. Deletion of NaV1.9 increases mechanosensory activation
thresholds of afferent fibres and reduces maintenance of repeated
responses
Our demonstration of a role for NaV1.9 in mechanical hypersen-
sitivity in response to IS prompted us to also determine how
NaV1.9 influences mechanosensation. To do this, we used
whole-nerve recordings of distension responses in a cannulated
tubular preparation of the distal colon, plus single-fibre recordingtechniques in a flat sheet preparation. Phasic distension of the
bowel to 80 mm Hg intraluminal pressure led to a robust initial
increase in afferent activity after adapting to a plateau phase for
the remainder of the 1 min distension (Fig. 7). Second and third
repeat distensions (at 9 min intervals) evoked smaller peak
responses until a stabilized peak response was reached by the
fourth to sixth distension. In NaV1.9/ mice, peak responses to
first distension were similar to control animals (P = .17, Fig. 7C).
However, afferent responses to subsequent repeat distension in
NaV1.9/ mice showed greater tachyphylaxis with significant
reductions observed by the third to sixth distensions (P < .001,
Fig. 7B, E).
These findings suggested a particular role for NaV1.9 in
responses to persistent stimuli. To investigate this role further,
we used a slow ramp distension paradigm. Initial ramp distensions
up to 80 mmHg intraluminal pressure evoked maintained whole-
nerve responses with a linear correlate between afferent activity
and pressure, reaching a maximum firing rate of 13.3 ± 3.7 spikes/s
(N = 6) in control animals. NaV1.9/ mice, by contrast, elicited
minimal activity during comparable ramp distensions, with a small
burst of firing observed at30 mmHg (maximum1.4 ± 0.6 spikes/s,
N = 6, P < .0001).We reasoned that rapid phasic distension in exper-
iments described above develops a more substantial stimulus to
mechanoreceptive afferents compared to a slow ramp fill, even up
to equivalent final pressures (80 mm Hg). Therefore, it should be
possible to overcome the lack of response to slow ramp distension
by increasing the stimulus to supraphysiologic distension pres-
sures. The maximum distension pressure achievable in mouse
Fig. 4. Effect of 3 lM PGE2 on colonic splanchnic nerve activity in NaV1.9+/+ and NaV1.9/ mice. Example rate histogram and neurogram response in NaV1.9+/+ (A) and
NaV1.9/ (B) mice to 3 lM PGE2. Below, expanded traces at baseline and after addition of 3 lM PGE2 and example action potential for each genotype. (C) Response profiles to
addition of 3 lM PGE2 in NaV1.9+/+ (N = 6) and NaV1.9/mice (N = 6). (D) Peak increase in nerve activity after addition of 3 lM PGE2 in NaV1.9+/+ (N = 6) and NaV1.9/ (N = 6)
mice. ⁄⁄P < .01, ⁄⁄⁄P < .001.
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(N = 10). Ramp distension to 145 mm Hg was thus used to provide
a stronger stimulus. Ramp distensions beyond 80 mmHg continued
to linearly increase afferent firing rates to a maximum of 34.6 ±
7.3 spikes/s in NaV1.9+/+ mice (Fig. 8A). However, in NaV1.9/mice,
afferent firing remained just above baseline (<2 spikes/s) up to
95 mm Hg, above which an exponential increase in firing was
observed reaching firing rates almost comparable to NaV1.9+/+ ani-
mals at 145 mm Hg (25.4 ± 7.8 spikes/s, Fig. 8B, C). Mechanical sen-
sitization of responses to noxious ramp distensions (80 mm Hg)
was investigated by intraluminal perfusion of IS. In NaV1.9+/+ mice,
perfusion of IS led to direct activation of basal afferent firing rates,
which was not observed in NaV1.9/mice (3.8 ± 0.6 spikes/s, N = 5
vs 0.0 ± 0.4 spikes/s N = 6; P < .001, unpaired t test). Responses to
ramp distension during IS perfusion were potentiated in NaV1.9+/+
mice, an effect not observed in NaV1.9/ mice up to 50 mmHg
(Fig. 8D). At greater ramp distension pressures, sensitized
responses were observed in NaV1.9/ tissues compared to control
experiments, which may reflect either the sensitization of afferent
fibres negative for NaV1.9 or recruitment of alternative sensitizing
mechanisms within NaV1.9-containing fibers.
The deficits in afferent mechanosensation that we observed
could be due to increased adaptation above threshold and/or altered
thresholds for activation in particular fibers. To identify whichdistension-sensitive afferent subtypewas altered inNaV1.9/mice,
we used established single-fibre recording techniques in a colonic
flat sheet preparation. Although von Frey probes enable the highly
reproducible and directed stimuli required to interrogate specific
afferent subtypes, they are unlikely to represent an in vivo stimulus
encountered by the intact bowel. There are 4 subtypes of lumbar
splanchnic nerve afferents characterized by their location and
responses to stroke, von Frey probe, and circumferential stretch:
mucosal, muscular, mesenteric, and serosal afferents [6]. Stimu-
lus–response curves to probewith increasingweight of vFhs of sero-
sal and muscular units was unchanged between genotype (P = .94
and P = .24, respectively), with no significant differences observed
in either mechanosensory thresholds or responses to circumferen-
tial stretch of the preparation (Fig. 9). We did observe a significant
reduction in mesenteric afferent responses to vFh probing, specifi-
cally lower-intensity probing (0.16–1 g vFh), with a corresponding
increase in mechanosensory threshold at these intensities (Fig. 9B,
E). No difference in conduction velocity was observed between
mechanoreceptors in control and NaV1.9/mice (mean conduction
velocity NaV1.9+/+ mice, 0.50 ± 0.03 m/s, n = 33, N = 10 vs NaV1.9/
mice, 0.52 ± 0.05 m/s, n = 52, N = 16; P = .82), signifying that action
potential propagation is unaffected by loss of NaV1.9. Together,
these data suggest that high-intensity mechanical stimulation of
colonic afferents (eg, 2 g vFh probing, >95 mm Hg ramp distension,
Fig. 5. Chemical and mechanical stimulation of single-fibre mechanoreceptive fields in mouse colon. Example colonic nerve activity to ring application (2 min) of
inflammatory soup (IS) over a receptive field located in the serosa of NaV1.9+/+ (A) and NaV1.9/ (B) mice. Probes with von Frey hair (2 g) were performed prior to and after IS
application. (C) Response to IS ring application in serosal and mesenteric receptive fields. (D) Afferent hypersensitivity after IS application was observed in NaV1.9+/+ mice in
both serosal and mesenteric units. This was not present in NaV1.9/ mice.
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deletion. However, knockout of NaV1.9 appears to decrease the sen-
sitivity of mesenteric afferents to low-intensity stimulation, which
accounts for the significant deficits observed inwhole-nerve record-
ings during ramp distension.
4. Discussion
Our data demonstrate that NaV1.9 is required for direct excit-
atory responses of colonic afferents to noxious inflammatory medi-
ators and is the subsequent development of mechanical
hypersensitivity. We show that NaV1.9 is involved in determining
the mechanosensory thresholds of a subset of colonic afferents
with receptive fields in the mesenteric attachments, and we pro-
vide evidence of a significant role for NaV1.9 during persistent
(repeat phasic distensions) or sustained (ramp distension) noxious
distension of the colon. Finally, we show that NaV1.9 is important
in the activation of visceral nociceptors located in the colonic ser-
osa and mesentery by mediators released during human inflamma-
tory disease.Given the polymodal nature of visceral afferents responsive to
noxious stimuli, there are likely points of convergence in the
molecular signalling pathways underlying action potential genera-
tion at their endings. These may provide valuable targets by which
future treatments could counteract mechanical hypersensitivity
induced by on-going inflammation. Voltage-gated sodium chan-
nels may represent such a convergence point. Of the peripherally
expressed sodium channels, valuable insight has been obtained
regarding the function of NaV1.7 and NaV1.8 in visceral chronic
pain, not least due to causal links to human pain syndromes
[17,40]. However, functional evidence for a role of NaV1.9 in the
activation of visceral afferents has not been extensively explored.
The data presented here suggest that NaV1.9 represents an impor-
tant regulator of specific aspects of sustained visceral afferent
excitability, especially in responses to inflammatory mediators.
It is known that the persistent sodium current defined by
NaV1.9 can be greatly enhanced by inflammatory mediators acting
at GPCRs via Gq/11/PKC and Gi/o/PKA intracellular signalling path-
ways [2,10,30,44]. In some studies, this has required the applica-
tion of multiple mediators [30], whereas in other studies, the
Fig. 6. Effect of inflammatory bowel disease (IBD) supernatants on colonic nerve activity. (A) Example rate histograms of colonic nerve activity to control supernatant in
NaV1.9+/+ mice and to Crohn disease (CD) tissue supernatant in NaV1.9+/+ and NaV1.9/ mice. (B) Example rate histograms of colonic nerve activity to ulcerative colitis (UC)
supernatant in both NaV1.9+/+ and NaV1.9/ mice. (C) Peak change in activity after addition of control (N = 3), IBD supernatants in NaV1.9+/+ (N = 7), and NaV1.9/ mice
(N = 6). In addition, CD and UC responses are plotted separately (right; N = 3–4 per genotype). ⁄P < .05, ⁄⁄P < .01 vs control; #P < .05, ##P < .01 NaV1.9+/+ vs NaV1.9/. (D)
Cytokine (IL-1b, IL-6, GM-CSF, TNF-a, and IL-8) levels in IBD (N = 7) and control (N = 3) supernatants applied to afferent nerve recordings. ⁄P < .05 vs control. (E) Responses to
ring application of CD supernatants over serosal and mesenteric receptive fields in NaV1.9+/+ and NaV1.9/ mice. (F) Number of responsive vs nonresponsive serosal and
mesenteric units when CD supernatants were applied.
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NaV1.9 currents [2,44]. Our study extends these observations by
examining the contribution of NaV1.9 to nociceptor activation at
the level of the nerve ending. We observe significantly reduced
colonic afferent firing in NaV1.9/ mice to individually applied
ATP and PGE2, even at supramaximal concentrations, demonstrat-
ing that NaV1.9 is required in the activation of nerve fibres by these
mediators. These findings suggest that the application of single
mediators is sufficient to enhance NaV1.9 currents and trigger
action potentials in visceral afferents. However, it is important tostress that other inflammatory mediators may also be present at
the afferent terminal due to ongoing interactions with immune
cells or gut microbiota. As a consequence, we cannot rule out the
possibility that multiple mediators may be acting to enhance
NaV1.9 currents. Another consideration is that both ATP and PGE2
can enhance currents generated by other sodium channels (eg,
NaV1.8 [2]) or ion channels [45,50]; however, our data suggest that
visceral afferent excitability to these mediators appears highly
dependent on NaV1.9. The magnitude of the effect to ATP was
potentially surprising given the relatively small proportion of colon
Fig. 7. Example rate histogram of colonic splanchnic nerve response to repeat phasic distension (0–80 mm Hg; 60 s; 10 min intervals) in NaV1.9+/+ (A) and NaV1.9/mice (B).
Average response profiles to the first (C) and sixth (D) phasic ramp distension in NaV1.9+/+ and NaV1.9/ mice. (E) Peak change in firing rate during sequential phasic
distensions (⁄P < .05; ⁄⁄P < .01; ⁄⁄⁄P < .001, unpaired t test).
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may reflect the engagement of alternative purinoceptors, including
P2Y receptors.
In addition to attenuating responses to single mediators, in
NaV1.9/ mice we also observed a substantial reduction in serosal
and mesenteric afferent firing after the application of an experi-
mental IS (consisting of bradykinin, histamine, PGE2, ATP, and
5HT). This indicates that NaV1.9 is required for visceral afferent
activation to a range of inflammatory mediators. To explore this
further, we generated supernatants by incubating resected tissue
from patients with IBD. These disease derived IBD supernatant–
evoked increases in afferent activity in whole-nerve recordings
from mouse colon, and in single-unit recordings from serosal and
mesenteric afferents; both were significantly attenuated in NaV1.9-
/ mice. Collectively, this suggests that during human inflamma-
tory disease where multiple inflammatory stimuli are present,
NaV1.9 contributes significantly to visceral afferent activation.
Deletion of NaV1.9 also caused significant deficits in mechano-
sensation and in the development of mechanical hypersensitivity
after application of inflammatory mediators. These deficits were
investigated using different mechanical stimuli, including von Frey
probing of isolated visceral nociceptor receptive fields, repeated
phasic distension of the colon at noxious pressures, and ramp dis-
tension of the colon into the noxious pressure range. Such studies
have proven invaluable in the development of our current under-
standing of how noxious mechanical stimulation of the gut is
transduced by visceral nociceptors [8,16,38]. We used vFh probes
to elicit brief, intense, and graded mechanical stimuli. These
responses were sensitized in both serosal and mesenteric afferents
after application of IS, an effect that is absent in NaV1.9/ mice.Furthermore, the response to noxious ramp distension was also
sensitized by IS, which, at least during lower distension pressures,
was dependent on NaV1.9. This is consistent with the proposed role
for NaV1.9 in regulating afferent nerve terminal sensitization
during inflammation [31].
We observed reduced baseline mechanosensitivity in mesen-
teric but not serosal or muscular afferents, suggesting that
NaV1.9 may contribute to the regulation of excitability in this affer-
ent subtype. Interestingly, mechanosensitivity is reduced in sero-
sal, but not mesenteric, afferents in ASIC2/ mice [38,48]. It
remains to be seen whether differences in the expression of
mechanotransducers or other known regulators of neuronal excit-
ability (such as T-type calcium channels or HCN2) present in sero-
sal vs mesenteric afferents contributes to the importance of NaV1.9
in regulating afferent firing remains [12,46].
Next we showed that the activation of visceral afferents by an
initial rapid phasic distension is unaffected by NaV1.9 deletion.
This observation supports the data generated using high-intensity
vFh (2 g) stimulation which produced comparable responses across
all types of units regardless of genotype. It suggests that the reduc-
tion in afferent excitability caused the loss of NaV1.9 may be over-
come by greater mechanical stimulation, and presumably greater
activation of stimulus-transducing channels. In contrast to the ini-
tial phasic distension, NaV1.9 is required for the maintenance of
afferent sensitivity to persistent mechanical stimuli. The desensiti-
zation in responses typically seen to repeat colorectal distension
[22,47] did not stabilize in NaV1.9/ mice but instead continued
to decline with subsequent distensions. One explanation for this
observation that is worthy of further investigation is that repeated
mechanical stimuli may progressively desensitise activity in
Fig. 8. Example rate histogram and raw trace of colonic splanchnic nerve response to ramp distension (0–145 mm Hg) in NaV1.9+/+ (A) and NaV1.9/ (B) mice with
intraluminal pressure trace. (C) Firing rates to distension pressures of <95 mm Hg were greatly attenuated in NaV1.9/ animals compared to NaV1.9+/+ mice (N = 6), with an
increase in firing at greater pressures in NaV1.9/ mice (P < .0001, 2-way ANOVA with Bonferroni’s post hoc test, ⁄P < .05; ⁄⁄P < .01; ⁄⁄⁄P < .001). (D) Firing rates to noxious
80 mm Hg ramp distension in NaV1.9+/+ and NaV1.9/ mice were increased by intraluminal perfusion with inflammatory soup (IS) (P < .0001, NaV1.9+/+ vs NaV1.9/, 2-way
ANOVA with Bonferroni’s post hoc test, ⁄P < .05; ⁄⁄P < .01; ⁄⁄⁄P < .001; P < .0001, NaV1.9+/+ in presence of IS vs NaV1.9/ in presence of IS, 2-way ANOVA with Bonferroni’s post
hoc test, #P < .05, ##P < .01, ###P < .001).
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however, a concurrent up-regulation of NaV1.9 maintains a consis-
tent level of afferent activation. This mechanism could be crucial
in vivo, where pain is evoked by repeated contractions of the colon
around a bolus or stricture [9]. Consistent with this proposed role
for NaV1.9 in persistent or sustained stimuli, we observed substan-
tial reductions in the afferent response to ramp colorectal disten-
sion in NaV1.9/ tissue at all pressures, including those within
the noxious range. When these pressures were extended into the
supramaximal range (100–150 mmHg), increases in afferent activ-
ity were observed in both genotypes. This is in keeping with our
previous suggestion that increased stimulus strength may over-
come the loss of excitability after deletion of NaV1.9.
Considerable efforts were taken to ensure that changes
observed in this study were not confounded by the loss of NaV1.9
within intrinsic primary afferents neurones (IPANs) of the enteric
nervous system (ENS) [37,43]. Potential impact of the loss of
NaV1.9 in IPANs on local motor reflexes was controlled by inhibit-
ing smooth muscle contractility through the addition of nifedipine
and atropine to the perfusion buffer. To reduce the probability of
recording activity from intestinofugal neurones within the ENS,
our recordings were made distil to the primary site of intestinofu-
gal afferent termination in the inferior mesenteric ganglia [29]. We
believe these steps, in conjunction with the magnitude of the
effects observed and paucity of evidence for cross-talk between
the ENS and extrinsic afferents, strongly suggest that the changeswe observed are due to modulation of neuronal excitability by
NaV1.9 in visceral extrinsic afferents [33]. Visceral afferents
responsive to noxious stimuli are relatively unspecialized anatom-
ically and therefore require mechanisms for regulating neuronal
excitation induced by a range of innocuous and noxious mechani-
cal and inflammatory stimuli [48]. Indeed, visceral nociceptors, in
particular serosal or mesenteric afferents, are prone to modulation
by inflammatory mediators, and they may be recruited after being
previously silent [5,7,15,16]. Our results suggest that NaV1.9 repre-
sents a significant mechanism responsible for regulating visceral
nociceptor sensitivity to sustained inflammatory and mechanical
stimuli (Fig. 10). The recent identification of gain-of-function
SCN11A mutations in humans resulting in both familial episodic
pain and painful neuropathy provides important evidence indicat-
ing that NaV1.9 is present in pain-sensing nerves in humans and
that modulating NaV1.9 function produces pain [20,54].
In summary, our data support an important physiological role
for NaV1.9 in the regulation of visceral afferent sensitivity during
inflammation, and one that will likely have clinical relevance to
human visceral pain. Further studies are required to fully under-
stand how inflammatory pathways interact with NaV1.9 within
the afferent fibre. The role of distinct sodium channel activity in
human afferent function has been indirectly addressed here by
combining human ex vivo samples with the use of null mutant
mice. This approach allows us to conclude that NaV1.9 is an impor-
tant target for the treatment of visceral pain.
Fig. 9. Stimulus–response curves to von Frey hair (vFh) probing for afferent fibre subtypes in NaV1.9+/+ and NaV1.9/ mice. Stimulus–response curves to vFh probing (0.07–
2 g) for serosal (A) and mesenteric (B) afferent fibres (2-way ANOVA with Bonferroni’s post hoc test, ⁄P < .05; ⁄⁄P < .01; ⁄⁄⁄P < .001). Associated activation thresholds of vFh
probing for serosal (C) and mesenteric (D) afferent fibres (Fisher’s exact test at each probe weight, ⁄⁄P < .01; ⁄⁄⁄P < .001).
Fig. 10. Schematic of NaV1.9 interacting with membrane-bound receptors and ion
channels in a visceral afferent terminal. When present at the visceral afferent
terminal, NaV1.9, as well as contributing to setting the resting membrane potential,
acts to amplify generator potentials evoked by mechanosensitive channels and
functions as a key transducer of inflammatory mediators and other sensitizing
stimuli.
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